Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-003899
Filing Date
2019-12-06
Accepted
2019-12-06 14:41:34
Documents
44
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ody_10q-103119.htm 10-Q 249233
2 CERTIFICATION ody_10q-ex3101.htm EX-31.1 7794
3 CERTIFICATION ody_10q-ex3102.htm EX-31.2 8073
4 CERTIFICATION ody_10q-ex032.htm EX-32 3766
  Complete submission text file 0001683168-19-003899.txt   1289894

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE odyy-20191031.xml EX-101.INS 115382
6 XBRL SCHEMA FILE odyy-20191031.xsd EX-101.SCH 19382
7 XBRL CALCULATION FILE odyy-20191031_cal.xml EX-101.CAL 28153
8 XBRL DEFINITION FILE odyy-20191031_def.xml EX-101.DEF 53925
9 XBRL LABEL FILE odyy-20191031_lab.xml EX-101.LAB 126300
10 XBRL PRESENTATION FILE odyy-20191031_pre.xml EX-101.PRE 108595
Mailing Address 2372 MORSE AVE. IRVINE CA 92614
Business Address 2372 MORSE AVE. IRVINE CA 92614 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-200785 | Film No.: 191272797
SIC: 2833 Medicinal Chemicals & Botanical Products